BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9839269)

  • 21. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.
    Simon JA; Reape KZ; Wininger S; Hait H
    Fertil Steril; 2008 Oct; 90(4):1132-8. PubMed ID: 18053998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of a novel vaginal ring delivering estradiol acetate versus oral estradiol for relief of vasomotor menopausal symptoms.
    Al-Azzawi F; Buckler HM;
    Climacteric; 2003 Jun; 6(2):118-27. PubMed ID: 12841882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen and its effect on vaginal atrophy in post-menopausal women.
    Kelley C
    Urol Nurs; 2007 Feb; 27(1):40-5. PubMed ID: 17390926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaginal ring an HT alternative.
    Cothran MM; Engberg S
    Nurse Pract; 2004 Jul; 29(7):54-5. PubMed ID: 15238860
    [No Abstract]   [Full Text] [Related]  

  • 26. [Urogenital atrophy and recurrent urinary tract infection in elderly patients].
    Salvat J; Capilna M; Schmidt MH
    Praxis (Bern 1994); 1997 Aug; 86(33):1249-53. PubMed ID: 9381010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
    Bachmann G; Lobo RA; Gut R; Nachtigall L; Notelovitz M
    Obstet Gynecol; 2008 Jan; 111(1):67-76. PubMed ID: 18165394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urogenital atrophy and low-dose vaginal estrogen therapy.
    Notelovitz M
    Menopause; 2000; 7(3):140-2. PubMed ID: 10810957
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical trial of the estradiol vaginal ring in the U.S.
    Nachtigall LE
    Maturitas; 1995 Dec; 22 Suppl():S43-7. PubMed ID: 8775777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of a soy-rich diet on urogenital atrophy: a randomized, cross-over trial.
    Manonai J; Songchitsomboon S; Chanda K; Hong JH; Komindr S
    Maturitas; 2006 May; 54(2):135-40. PubMed ID: 16297576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of vaginal estrogen in Danish women: a nationwide cross-sectional study.
    Meaidi A; Goukasian I; Lidegaard O
    Acta Obstet Gynecol Scand; 2016 Mar; 95(3):280-4. PubMed ID: 26646469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic data on estradiol in light of the estring concept. Estradiol and estring pharmacokinetics.
    Gabrielsson J; Wallenbeck I; Birgerson L
    Acta Obstet Gynecol Scand Suppl; 1996; 163():26-31; discussion 32-4. PubMed ID: 8916472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy.
    Smith P; Heimer G; Lindskog M; Ulmsten U
    Maturitas; 1993 Mar; 16(2):145-54. PubMed ID: 8483427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen ring use for genitourinary atrophy and menopausal symptomatology.
    Thacker HL
    Geriatrics; 2004 May; 59(5):34, 36-7. PubMed ID: 15152734
    [No Abstract]   [Full Text] [Related]  

  • 35. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women.
    Hedrick RE; Ackerman RT; Koltun WD; Halvorsen MB; Lambrecht LJ
    Menopause; 2009; 16(1):132-40. PubMed ID: 18971794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urogenital atrophy: diagnosis, sequelae, and management.
    Keil K
    Curr Womens Health Rep; 2002 Aug; 2(4):305-11. PubMed ID: 12150759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women.
    Dessole S; Rubattu G; Ambrosini G; Gallo O; Capobianco G; Cherchi PL; Marci R; Cosmi E
    Menopause; 2004; 11(1):49-56. PubMed ID: 14716182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical platform for the 17beta-estradiol vaginal releasing ring.
    Bachmann GA
    Am J Obstet Gynecol; 1998 May; 178(5):S257-60. PubMed ID: 9609602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post menopausal hormone therapy today.
    Rice VM
    Ethn Dis; 2005; 15(2 Suppl 2):S34-9. PubMed ID: 15822836
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of vaginal estrogen in the treatment of urogenital dysfunction in postmenopausal women.
    Bernier F; Jenkins P
    Urol Nurs; 1997 Sep; 17(3):92-5. PubMed ID: 9349043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.